IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-04134-7.html
   My bibliography  Save this article

NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells

Author

Listed:
  • Gene I. Uenishi

    (University of Wisconsin
    University of Wisconsin School of Medicine and Public Health)

  • Ho Sun Jung

    (University of Wisconsin)

  • Akhilesh Kumar

    (University of Wisconsin)

  • Mi Ae Park

    (University of Wisconsin)

  • Brandon K. Hadland

    (University of Washington School of Medicine
    Fred Hutchinson Cancer Research Center)

  • Ethan McLeod

    (University of Wisconsin)

  • Matthew Raymond

    (University of Wisconsin
    University of Wisconsin School of Veterinary Medicine)

  • Oleg Moskvin

    (University of Wisconsin)

  • Catherine E. Zimmerman

    (University of Wisconsin)

  • Derek J. Theisen

    (University of Wisconsin)

  • Scott Swanson

    (Morgridge Institute for Research)

  • Owen Tamplin

    (University of Illinois)

  • Leonard I. Zon

    (Harvard Medical School and Howard Hughes Medical Institute)

  • James A. Thomson

    (Morgridge Institute for Research
    University of Wisconsin School of Medicine and Public Health
    University of California)

  • Irwin D. Bernstein

    (University of Washington School of Medicine
    Fred Hutchinson Cancer Research Center)

  • Igor I. Slukvin

    (University of Wisconsin
    University of Wisconsin School of Medicine and Public Health
    University of Wisconsin School of Medicine and Public Health)

Abstract

NOTCH signaling is required for the arterial specification and formation of hematopoietic stem cells (HSCs) and lympho-myeloid progenitors in the embryonic aorta-gonad-mesonephros region and extraembryonic vasculature from a distinct lineage of vascular endothelial cells with hemogenic potential. However, the role of NOTCH signaling in hemogenic endothelium (HE) specification from human pluripotent stem cell (hPSC) has not been studied. Here, using a chemically defined hPSC differentiation system combined with the use of DLL1-Fc and DAPT to manipulate NOTCH, we discover that NOTCH activation in hPSC-derived immature HE progenitors leads to formation of CD144+CD43−CD73−DLL4+Runx1 + 23-GFP+ arterial-type HE, which requires NOTCH signaling to undergo endothelial-to-hematopoietic transition and produce definitive lympho-myeloid and erythroid cells. These findings demonstrate that NOTCH-mediated arterialization of HE is an essential prerequisite for establishing definitive lympho-myeloid program and suggest that exploring molecular pathways that lead to arterial specification may aid in vitro approaches to enhance definitive hematopoiesis from hPSCs.

Suggested Citation

  • Gene I. Uenishi & Ho Sun Jung & Akhilesh Kumar & Mi Ae Park & Brandon K. Hadland & Ethan McLeod & Matthew Raymond & Oleg Moskvin & Catherine E. Zimmerman & Derek J. Theisen & Scott Swanson & Owen Tamp, 2018. "NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells," Nature Communications, Nature, vol. 9(1), pages 1-14, December.
  • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04134-7
    DOI: 10.1038/s41467-018-04134-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-04134-7
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-018-04134-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. B. Edginton-White & A. Maytum & S. G. Kellaway & D. K. Goode & P. Keane & I. Pagnuco & S. A. Assi & L. Ames & M. Clarke & P. N. Cockerill & B. Göttgens & J. B. Cazier & C. Bonifer, 2023. "A genome-wide relay of signalling-responsive enhancers drives hematopoietic specification," Nature Communications, Nature, vol. 14(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04134-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.